FDA Clearance Tracker · P010047
PROGEL PLEURAL AIR LEAK SEALANT
Last checked: Nov 19, 2026Latest source record: Jan 14, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2010
Approved
Time to decision
3,066 days
Received Aug 23, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P010047
- Device name
- PROGEL PLEURAL AIR LEAK SEALANT
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- Aug 23, 2001
- Decided
- Jan 14, 2010
- Decision
- Approved
- Supplements
- 67 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR PROGEL PLEURAL AIR LEAK SEALANT. THE DEVICE IS INDICATED FOR APPLICATION TO VISCERAL PLEURA DURING AN OPEN THORACOTOMY AFTER STANDARD VISCERAL PLEURAL CLOSURE WITH, FOR EXAMPLE, SUTURES OR STAPLES, OF VISIBLE AIR LEAKS (>=2 MM) INCURRED DURING OPEN RESECTION OF LUNG PARENCHYMA.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NBE. The earliest in FDA's data is P990028, decided May 26, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
- PROGEL PLEURAL AIR LEAK SEALANTPMA supplement
P010047-S036 · Decided Feb 13, 2015 · 217 days after receipt · Panel Track
Device type: Sealant, polymerizing (NBE) · Anesthesiology & Respiratory
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.